annual cash & cash equivalents:
$2.16B-$562.30M(-20.65%)Summary
- As of today (June 2, 2025), HOLX annual cash & cash equivalents is $2.16 billion, with the most recent change of -$562.30 million (-20.65%) on September 30, 2024.
- During the last 3 years, HOLX annual cash & cash equivalents has risen by +$989.90 million (+84.59%).
- HOLX annual cash & cash equivalents is now -20.65% below its all-time high of $2.72 billion, reached on September 30, 2023.
Performance
HOLX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.43B-$352.60M(-19.79%)Summary
- As of today (June 2, 2025), HOLX quarterly cash & cash equivalents is $1.43 billion, with the most recent change of -$352.60 million (-19.79%) on March 29, 2025.
- Over the past year, HOLX quarterly cash & cash equivalents has dropped by -$750.50 million (-34.43%).
- HOLX quarterly cash & cash equivalents is now -48.30% below its all-time high of $2.77 billion, reached on June 1, 2023.
Performance
HOLX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HOLX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.6% | -34.4% |
| 3 y3 years | +84.6% | -37.6% |
| 5 y5 years | +259.0% | +78.7% |
HOLX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.6% | +84.6% | -48.3% | at low |
| 5 y | 5-year | -20.6% | +259.0% | -48.3% | +103.9% |
| alltime | all time | -20.6% | >+9999.0% | -48.3% | >+9999.0% |
HOLX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.43B(-19.8%) |
| Dec 2024 | - | $1.78B(-17.5%) |
| Sep 2024 | $2.16B(-20.7%) | $2.16B(-11.4%) |
| Jun 2024 | - | $2.44B(+11.9%) |
| Mar 2024 | - | $2.18B(+12.8%) |
| Dec 2023 | - | $1.93B(-29.0%) |
| Sep 2023 | $2.72B(+16.4%) | $2.72B(-1.5%) |
| Jun 2023 | - | $2.77B(+7.1%) |
| Mar 2023 | - | $2.58B(+5.8%) |
| Dec 2022 | - | $2.44B(+4.4%) |
| Sep 2022 | $2.34B(+99.9%) | $2.34B(-1.5%) |
| Jun 2022 | - | $2.38B(+3.7%) |
| Mar 2022 | - | $2.29B(+61.2%) |
| Dec 2021 | - | $1.42B(+21.4%) |
| Sep 2021 | $1.17B(+66.9%) | $1.17B(+41.4%) |
| Jun 2021 | - | $827.60M(+1.4%) |
| Mar 2021 | - | $816.40M(-6.0%) |
| Dec 2020 | - | $868.70M(+23.9%) |
| Sep 2020 | $701.00M(+16.5%) | $701.00M(-5.8%) |
| Jun 2020 | - | $744.20M(-7.0%) |
| Mar 2020 | - | $799.80M(+115.7%) |
| Dec 2019 | - | $370.80M(-38.4%) |
| Sep 2019 | $601.80M(-9.7%) | $601.80M(+40.6%) |
| Jun 2019 | - | $427.90M(+6.7%) |
| Mar 2019 | - | $401.00M(+28.9%) |
| Dec 2018 | - | $311.10M(-53.3%) |
| Sep 2018 | $666.70M(+23.3%) | $666.70M(+15.9%) |
| Jun 2018 | - | $575.40M(-6.3%) |
| Mar 2018 | - | $614.20M(-7.6%) |
| Dec 2017 | - | $664.40M(+22.9%) |
| Sep 2017 | $540.60M(-1.4%) | $540.60M(-8.1%) |
| Jun 2017 | - | $588.40M(-48.1%) |
| Mar 2017 | - | $1.13B(+75.6%) |
| Dec 2016 | - | $646.00M(+17.8%) |
| Sep 2016 | $548.40M(+11.6%) | $548.40M(+24.2%) |
| Jun 2016 | - | $441.50M(+39.6%) |
| Mar 2016 | - | $316.30M(-51.4%) |
| Dec 2015 | - | $650.30M(+32.4%) |
| Sep 2015 | $491.30M(-33.3%) | $491.30M(-44.5%) |
| Jun 2015 | - | $885.00M(+32.0%) |
| Mar 2015 | - | $670.50M(+23.3%) |
| Dec 2014 | - | $544.00M(-26.1%) |
| Sep 2014 | $736.10M(-10.5%) | $736.10M(+16.4%) |
| Jun 2014 | - | $632.50M(+30.5%) |
| Mar 2014 | - | $484.52M(+9.5%) |
| Dec 2013 | - | $442.49M(-46.2%) |
| Sep 2013 | $822.50M(+46.8%) | $822.50M(-14.2%) |
| Jun 2013 | - | $958.44M(+28.7%) |
| Mar 2013 | - | $745.00M(+3.7%) |
| Dec 2012 | - | $718.47M(+28.2%) |
| Sep 2012 | $560.43M(-21.3%) | $560.43M(-38.1%) |
| Jun 2012 | - | $905.08M(+5.9%) |
| Mar 2012 | - | $854.56M(+7.8%) |
| Dec 2011 | - | $793.08M(+11.3%) |
| Sep 2011 | $712.33M(+38.1%) | $712.33M(+16.1%) |
| Jun 2011 | - | $613.80M(+7.1%) |
| Mar 2011 | - | $572.92M(-5.8%) |
| Dec 2010 | - | $608.04M(+17.9%) |
| Sep 2010 | $515.63M(+75.9%) | $515.63M(+4.9%) |
| Jun 2010 | - | $491.37M(+13.9%) |
| Mar 2010 | - | $431.31M(+25.0%) |
| Dec 2009 | - | $345.04M(+17.7%) |
| Sep 2009 | $293.19M(+206.5%) | $293.19M(+20.3%) |
| Jun 2009 | - | $243.72M(+12.2%) |
| Mar 2009 | - | $217.23M(+26.7%) |
| Dec 2008 | - | $171.48M(+79.3%) |
| Sep 2008 | $95.66M | $95.66M(-20.2%) |
| Jun 2008 | - | $119.86M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $97.80M(-36.8%) |
| Dec 2007 | - | $154.66M(+54.0%) |
| Sep 2007 | $100.40M(+235.5%) | $100.40M(+7.0%) |
| Jun 2007 | - | $93.80M(+72.1%) |
| Mar 2007 | - | $54.50M(+46.1%) |
| Dec 2006 | - | $37.31M(+24.7%) |
| Sep 2006 | $29.92M(-73.8%) | $29.92M(-72.8%) |
| Jun 2006 | - | $110.14M(+1.7%) |
| Mar 2006 | - | $108.28M(+14.6%) |
| Dec 2005 | - | $94.51M(-17.1%) |
| Sep 2005 | $113.99M(+66.8%) | $113.99M(+11.5%) |
| Jun 2005 | - | $102.25M(+6.9%) |
| Mar 2005 | - | $95.69M(+31.6%) |
| Dec 2004 | - | $72.70M(+6.4%) |
| Sep 2004 | $68.33M(+51.3%) | $68.33M(+20.0%) |
| Jun 2004 | - | $56.94M(+1.4%) |
| Mar 2004 | - | $56.13M(+24.7%) |
| Dec 2003 | - | $45.02M(-0.4%) |
| Sep 2003 | $45.18M(-1.4%) | $45.18M(+13.3%) |
| Jun 2003 | - | $39.87M(+26.9%) |
| Mar 2003 | - | $31.42M(-27.3%) |
| Dec 2002 | - | $43.21M(-5.7%) |
| Sep 2002 | $45.84M(+259.4%) | $45.84M(+43.5%) |
| Jun 2002 | - | $31.94M(+21.8%) |
| Mar 2002 | - | $26.23M(-14.3%) |
| Dec 2001 | - | $30.60M(+139.9%) |
| Sep 2001 | $12.75M(-44.0%) | $12.75M(+7.1%) |
| Jun 2001 | - | $11.91M(-26.3%) |
| Mar 2001 | - | $16.17M(-27.7%) |
| Dec 2000 | - | $22.36M(-1.8%) |
| Sep 2000 | $22.78M(-37.6%) | $22.78M(-33.2%) |
| Jun 2000 | - | $34.10M(-7.1%) |
| Mar 2000 | - | $36.72M(+1.7%) |
| Dec 1999 | - | $36.10M(-1.1%) |
| Sep 1999 | $36.50M(-24.6%) | $36.50M(-4.9%) |
| Jun 1999 | - | $38.40M(+4.9%) |
| Mar 1999 | - | $36.60M(-24.4%) |
| Dec 1998 | - | $48.40M(0.0%) |
| Sep 1998 | $48.40M(+72.2%) | $48.40M(+5.4%) |
| Jun 1998 | - | $45.90M(+5.0%) |
| Mar 1998 | - | $43.70M(-3.3%) |
| Dec 1997 | - | $45.20M(+60.9%) |
| Sep 1997 | $28.10M(-2.4%) | $28.10M(-15.6%) |
| Jun 1997 | - | $33.30M(-21.8%) |
| Mar 1997 | - | $42.60M(+28.3%) |
| Dec 1996 | - | $33.20M(+15.3%) |
| Sep 1996 | $28.80M(+289.2%) | $28.80M(-9.4%) |
| Jun 1996 | - | $31.80M(-45.1%) |
| Mar 1996 | - | $57.90M(+606.1%) |
| Dec 1995 | - | $8.20M(+10.8%) |
| Sep 1995 | $7.40M(+25.4%) | $7.40M(+10.4%) |
| Jun 1995 | - | $6.70M(-31.6%) |
| Mar 1995 | - | $9.80M(+18.1%) |
| Dec 1994 | - | $8.30M(+40.7%) |
| Sep 1994 | $5.90M(-11.9%) | $5.90M(+68.6%) |
| Jun 1994 | - | $3.50M(-25.5%) |
| Mar 1994 | - | $4.70M(+6.8%) |
| Dec 1993 | - | $4.40M(-34.3%) |
| Sep 1993 | $6.70M(+179.2%) | $6.70M(+6.3%) |
| Jun 1993 | - | $6.30M(+80.0%) |
| Mar 1993 | - | $3.50M(+45.8%) |
| Sep 1992 | $2.40M(-73.3%) | $2.40M(-41.5%) |
| Jun 1992 | - | $4.10M(+105.0%) |
| Mar 1992 | - | $2.00M(-58.3%) |
| Dec 1991 | - | $4.80M(-46.7%) |
| Sep 1991 | $9.00M(-32.8%) | $9.00M(-32.8%) |
| Sep 1990 | $13.40M(+570.0%) | $13.40M(+38.1%) |
| Mar 1990 | - | $9.70M(+385.0%) |
| Sep 1989 | $2.00M | $2.00M |
FAQ
- What is Hologic annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Hologic?
- What is Hologic annual cash & cash equivalents year-on-year change?
- What is Hologic quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Hologic?
- What is Hologic quarterly cash & cash equivalents year-on-year change?
What is Hologic annual cash & cash equivalents?
The current annual cash & cash equivalents of HOLX is $2.16B
What is the all time high annual cash & cash equivalents for Hologic?
Hologic all-time high annual cash & cash equivalents is $2.72B
What is Hologic annual cash & cash equivalents year-on-year change?
Over the past year, HOLX annual cash & cash equivalents has changed by -$562.30M (-20.65%)
What is Hologic quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of HOLX is $1.43B
What is the all time high quarterly cash & cash equivalents for Hologic?
Hologic all-time high quarterly cash & cash equivalents is $2.77B
What is Hologic quarterly cash & cash equivalents year-on-year change?
Over the past year, HOLX quarterly cash & cash equivalents has changed by -$750.50M (-34.43%)